New Zealand markets closed

Profound Medical Corp. (PROF)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.49+0.20 (+2.74%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.29
Open7.30
Bid2.94 x 1000
Ask11.74 x 1000
Day's range7.27 - 7.49
52-week range6.09 - 18.26
Volume3,480
Avg. volume35,329
Market cap155.638M
Beta (5Y monthly)1.51
PE ratio (TTM)N/A
EPS (TTM)-1.53
Earnings date02 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est17.81
  • GlobeNewswire

    Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference

    TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that its CEO and Chairman, Arun Menawat, will participate in a virtual panel discussion on Focused Ultrasound hosted by Joshua Jennings, M.D., Managing Director, Health Care - Medical Supplies & Devices, at Cowen’s 7th An

  • Simply Wall St.

    What You Need To Know About Profound Medical Corp.'s (TSE:PRN) Investor Composition

    A look at the shareholders of Profound Medical Corp. ( TSE:PRN ) can tell us which group is most powerful. Large...

  • GlobeNewswire

    Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference

    TORONTO, June 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2022 Jefferies Global Healthcare Conference in New York City on Thursday, June 9, 2022 at 4:30 p.m. Eastern Time.The presentation will be broadcast l